The Prognostic Value of 2-Deoxy-2-[18F]Fluoro-d-Glucose Positron Emission Tomography in Patients With Suspected Residual or Recurrent Medullary Thyroid Carcinoma

2009 ◽  
Vol 12 (5) ◽  
pp. 547-553 ◽  
Author(s):  
Trond Velde Bogsrud ◽  
Dimitrios Karantanis ◽  
Mark A. Nathan ◽  
Brian P. Mullan ◽  
Gregory A. Wiseman ◽  
...  
Keyword(s):  
Positron Emission Tomography ◽  
Thyroid Carcinoma ◽  
Medullary Thyroid Carcinoma ◽  
Prognostic Value ◽  
Emission Tomography ◽  
Medullary Thyroid ◽  
Positron Emission

Detection Rate of Recurrent Medullary Thyroid Carcinoma Using Fluorine-18 Dihydroxyphenylalanine Positron Emission Tomography

2012 ◽  
Vol 19 (10) ◽  
pp. 1290-1299 ◽  
Author(s):  
Giorgio Treglia ◽  
Fabrizio Cocciolillo ◽  
Francesco Di Nardo ◽  
Andrea Poscia ◽  
Chiara de Waure ◽  
...  
Keyword(s):  
Positron Emission Tomography ◽  
Thyroid Carcinoma ◽  
Medullary Thyroid Carcinoma ◽  
Detection Rate ◽  
Emission Tomography ◽  
Medullary Thyroid ◽  
Positron Emission

Breast metastasis by medullary thyroid carcinoma detected by FDG positron emission tomography

2008 ◽  
Vol 12 (1) ◽  
pp. 67-71 ◽  
Author(s):  
Sharon Nofech-Mozes ◽  
Robert Mackenzie ◽  
Harriette J. Kahn ◽  
Lisa Ehrlich ◽  
Simon J. Raphael
Keyword(s):  
Positron Emission Tomography ◽  
Thyroid Carcinoma ◽  
Medullary Thyroid Carcinoma ◽  
Emission Tomography ◽  
Breast Metastasis ◽  
Medullary Thyroid ◽  
Positron Emission

scholarly journals Medullary Thyroid Carcinoma: An Update on Imaging

2019 ◽  
Vol 2019 ◽  
pp. 1-17 ◽  
Author(s):  
Sergiy V. Kushchayev ◽  
Yevgeniya S. Kushchayeva ◽  
Sri Harsha Tella ◽  
Tetiana Glushko ◽  
Karel Pacak ◽  
...  
Keyword(s):  
Positron Emission Tomography ◽  
Magnetic Resonance ◽  
Thyroid Carcinoma ◽  
Lymph Nodes ◽  
Medullary Thyroid Carcinoma ◽  
Emission Tomography ◽  
Imaging Modalities ◽  
Whole Body ◽  
Medullary Thyroid ◽  
Positron Emission

Medullary thyroid carcinoma (MTC), arising from the parafollicular C cells of the thyroid, accounts for 1–2% of thyroid cancers. MTC is frequently aggressive and metastasizes to cervical and mediastinal lymph nodes, lungs, liver, and bones. Although a number of new imaging modalities for directing the management of oncologic patients evolved over the last two decades, the clinical application of these novel techniques is limited in MTC. In this article, we review the biology and molecular aspects of MTC as an important background for the use of current imaging modalities and approaches for this tumor. We discuss the modern and currently available imaging techniques—advanced magnetic resonance imaging (MRI)-based techniques such as whole-body MRI, dynamic contrast-enhanced (DCE) technique, diffusion-weighted imaging (DWI), positron emission tomography/computed tomography (PET/CT) with 18F-FDOPA and 18F-FDG, and integrated positron emission tomography/magnetic resonance (PET/MR) hybrid imaging—for primary as well as metastatic MTC tumor, including its metastatic spread to lymph nodes and the most common sites of distant metastases: lungs, liver, and bones.

Sign in / Sign up

Export Citation Format

Share Document